PJAClass II
Coronary Vascular Physiologic Simulation Software
21 CFR 870.1415 / Cardiovascular
PJA is the FDA product code for Coronary Vascular Physiologic Simulation Software, a class II device type, regulated under 21 CFR 870.1415. FDA's definition for this code reads: "A coronary vascular physiologic simulation software device is intended to aid in the identification of functionally significant cardiovascular disease". As of , FDA records hold 9 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PJA
- Device name
- Coronary Vascular Physiologic Simulation Software
- FDA definition
- A coronary vascular physiologic simulation software device is intended to aid in the identification of functionally significant cardiovascular disease.
- Regulation
- 21 CFR 870.1415
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 9
- Ingested recalls
- 0
Clearances, product code PJA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Applicants with the most clearances
Product code PJA| Applicant | Clearances |
|---|---|
| Heartflow, Inc. | 8 |
| Keyamed Na, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
